Dysgeusia News and Research

RSS
Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Scientists discover key brain cells affected by COVID-19

Scientists discover key brain cells affected by COVID-19

Study finds evidence of SARS-CoV-2 exposure in many patients with postviral syndrome

Study finds evidence of SARS-CoV-2 exposure in many patients with postviral syndrome

Does COVID-19 increase the risk of future gastrointestinal disorders?

Does COVID-19 increase the risk of future gastrointestinal disorders?

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Investigating the role of T-cell immunity in long COVID

Investigating the role of T-cell immunity in long COVID

Substance P neuropeptides' role in post-COVID-19 conditions suggested in recent study

Substance P neuropeptides' role in post-COVID-19 conditions suggested in recent study

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

Biomarkers that can predict long COVID symptoms

Biomarkers that can predict long COVID symptoms

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Large study on post-COVID dysosmia and dysgeusia

Large study on post-COVID dysosmia and dysgeusia

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

What is the long-term cognitive impact of COVID-19, and what are its predictors?

What is the long-term cognitive impact of COVID-19, and what are its predictors?

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

What are the risk factors associated with symptomatic SARS-CoV-2 and rhinovirus infection in King County, Washington, from June 2020 to July 2022?

What are the risk factors associated with symptomatic SARS-CoV-2 and rhinovirus infection in King County, Washington, from June 2020 to July 2022?

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

Long COVID brain fog and fatigue negatively impact all facets of daily life

Long COVID brain fog and fatigue negatively impact all facets of daily life

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment